Iron therapy resistant microcytic anemia a form of presentation of Castleman disease;Anemia ferropenica refractaria al tratamiento oral con hierro, como forma de presentacion de la enfermedad de castleman

Anales Espanoles de Pediatria

Volumn 51, Issue 1, 1999, Pages 74-76

  Torres Valdivieso, María José ^a   Lopez Perez J ^a   Melero Moreno, C ^a   Vivanco Martinez J L ^a   Peralta Ibanez Ma L ^a   Nieto Del Rincon N ^a   Perez Campos A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; ENTERITIS; HUMAN; INTESTINE BIOPSY; IRON THERAPY; MICROCYTIC ANEMIA; ABDOMINAL RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; IRON INTAKE; MACROCYTIC ANEMIA; REFRACTORY ANEMIA;

ANEMIA, MACROCYTIC; ANEMIA, REFRACTORY; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IRON, DIETARY; RADIOGRAPHY, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0345035222     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. De Heer-Groen TA, Prakken ABJ, Bax NMA and Van Dijken PJ. Iron therapy resistant microcytic anaemia in a 13-year-old girl with Castleman disease. Eur J Pediatr 1996; 155:1015-1017.
2. Castleman B, Iverson L, Menéndez VP. Localized mediastinal limphnode hyperplasia resembling thymoma. Cancer 1956; 9:822-830.
3. Frizzera G, Castleman's disease: more questions than answers. Hum Pathol 1985; 16:202-205.
4. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and others locations. Cancer 1972; 29:670-683.
5. Shahidi MD, Myers JL, Kvale PA. Castleman's Disease: subject review. Mayo Clin Proc 1995; 70:969-977.
6. Leger-Ravet MB, Peuchmaur M, Devergne O. et al. Interleukin-6 gene expression in Castleman's disease. Blood 1991; 78:2923-2930.
7. Bjarnason I, Cotes PM, Knowles S. et al. Giant Lymph Node Hyperplasia (Castleman's Disease) of the Mesentery. Observations on the associated anemia. Gastroenterology 1984; 87:216-223.
8. Lee SL, Rosner F, Rivero I et al. Refractory anemia with abnormal iron metabolism. Its remission after resection of hyperplastic mediastinal lymph nodes. N Engl J Med 1965; 272:761-766.
9. Gerald W, Kostianovsky M, Rosai J. Development of vascular neoplasia in Castleman's disease: report of seven cases. Am J Surg Pathol 1990; 14:603-614.
10. Peterson BA, Frizzera G. Multicentric Castleman's disease. Seminars in Oncology 1993; 20:636-647.
11. Beck JT, Hsu S, Wijdenes J. et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994; 330:602-605.
12. Pavlidis NA, Briassoulis E, Klouvas G. et al. Is interferon-α an active agent in Castleman's disease?. Annals of Oncology 1992; 3:85-86.
13. Bordeleau L, Bredeson C, Markman S. 2-Chloro-deoxyadenosine therapy for giant lymph node hyperplasia. British Journal of Haematol 1995; 91:668-670.